MSR30 Modelling Monthly Migraine Day Distribution: A Case Study of Fremanezumab Japanese-Korean Clinical Trials for Migraine Prevention
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1237
https://www.valueinhealthjournal.com/article/S1098-3015(22)01438-3/fulltext
Title :
MSR30 Modelling Monthly Migraine Day Distribution: A Case Study of Fremanezumab Japanese-Korean Clinical Trials for Migraine Prevention
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01438-3&doi=10.1016/j.jval.2022.04.1237
First page :
Section Title :
Open access? :
No
Section Order :
11103